• Resources
  • Blog
  • Journalists
  • Log In
  • Sign Up
  • Data Privacy
  • Send a Release
Cision PR Newswire: news distribution, targeting and monitoring home
  • News
  • Products
  • Contact

 

When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Overview
  • Distribution by PR Newswire
  • Cision Communications Cloud®
  • Cision IR
  • Sponsored Placement
  • All Products
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • Overview
  • Distribution by PR Newswire
  • Cision Communications Cloud®
  • Cision IR
  • All Products
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR

First-of-its-Kind Diabetes Technology Revolutionizes How Glucose Data is Collected and Analyzed for People in India

- ABBOTT RECEIVES APPROVAL IN INDIA FOR FREESTYLE® LIBRE PRO FLASH GLUCOSE MONITORING SYSTEM

- INDIA IS FIRST COUNTRY TO LAUNCH NEW PROFESSIONAL-USE DEVICE, DESIGNED TO HELP DOCTORS TREAT PATIENTS WITH DIABETES

- SYSTEM MEASURES GLUCOSE LEVELS THROUGH SMALL SENSOR ON THE BACK OF THE UPPER ARM


News provided by

Abbott

Apr 02, 2015, 09:00 ET

Share this article

Share this article


ABBOTT PARK, Ill., April 2, 2015 /PRNewswire/ -- India has the third highest population of obesity, trailing only the United States and China.[1]  Nutrition, lifestyle and demographic transitions in India have led to a decline in overall health[2]—and for many, that also means a rise in diseases such as diabetes.

To provide tools to better manage diabetes, Abbott (NYSE: ABT) has launched the FreeStyle® Libre Pro Flash Glucose Monitoring System in India—a transformative new glucose monitoring tool that fundamentally changes how doctors treat people with diabetes.  With this tool, doctors can get the comprehensive glucose data they need to make more informed treatment decisions. They can personalize their patient's diabetes treatment plans, allowing people to better manage their disease.

According to the International Diabetes Federation, India today has a diabetes population of 65.1 million compared to 50.8 million in 2010[3].  A recent survey conducted by the Association of Physicians of India (API) and sponsored by Abbott[4] showed that 90 percent of people surveyed with uncontrolled diabetes [HbA1c level higher than 7 percent] in India continue to believe that they have control over their glucose levels, despite facts suggesting otherwise. 

"India now carries 20 percent of the global burden of diabetes," said Robert Ford, senior vice president, Diabetes Care, Abbott.  "There is an immense need for people in India to better manage their diabetes, enabling them to live healthier lives. Abbott's FreeStyle Libre Pro System is designed to empower doctors in India to help their patients through rich data and actionable insights."

FREESTYLE LIBRE PRO SYSTEM—A COMPLETE GLYCEMIC PROFILE

As evidenced by the API survey, one of the main challenges among people with diabetes in India is that self-monitoring of blood glucose is not a common practice. The FreeStyle Libre Pro ("Pro" indicating "Professional" version) Flash Glucose Monitoring System is designed to be applied by healthcare professionals in a clinic setting. The FreeStyle Libre Pro System consists of a small, round sensor—slightly larger than a 10 rupee coin (size of a U.S. quarter). A healthcare professional applies the sensor on the back of the patient's upper arm.  The sensor is held in place with a self-adhesive pad and remains on the back of the arm for up to 14 days, requiring no patient interaction or finger-prick calibration.  

When applied to the back of the arm, the sensor continuously measures glucose in interstitial fluid through a small (5mm long, 0.4mm wide) filament that is inserted just under the skin. It records glucose levels every 15 minutes, capturing up to 1340 glucose results over 14 days, giving the treating doctor comprehensive data for a complete glycemic profile of their patient.  After 14 days, the person returns to the doctor's office, where the doctor uses a FreeStyle Libre Pro reader device to scan the sensor and download the glucose results that are stored in the sensor—in as quickly as five seconds.

"Diabetes is already at epidemic proportions and there is an urgent need to manage it better," said Dr. V. Mohan, Director and Chief of Diabetes Research at Madras Diabetes Research Foundation. "Current diabetes monitoring tools are limiting for doctors because they don't reveal a complete picture of the glucose variability that a person goes through during a day. The revolutionary flash glucose monitoring system will be very useful for doctors in getting complete glucose profiles of their patients. This will help us in our clinical decision making as well as in personalizing treatment plans for better outcomes."

THE IMPORTANCE OF VISUALIZING THE COMPLETE GLYCEMIC PROFILE

The FreeStyle Libre Pro System provides physicians with the Ambulatory Glucose Profile (AGP), a report generated from comprehensive glucose data that provides a visual snapshot of a person's typical day—revealing hypoglycemic and hyperglycemic trends to facilitate better patient therapy and education. Healthcare professionals are able to understand how their patients' glucose levels change as they go about their daily life, which helps them personalize how they treat their patients. The data are presented in a single, user-friendly, visual chart providing health care professionals the vantage point to link an individual's glucose trends to clinical decision-making, enabling more informed and personalized treatment decisions and more productive discussions between the health care professional and patient.

"Current systems for continuous measurement of glucose are cumbersome and require regular finger-pricking to ensure they are calibrated correctly for accuracy," said Jared Watkin, divisional vice president, Technical Operations, Diabetes Care, Abbott.  "Based on insights from our customers, the focus for our design team has been to innovate for these challenges, while also providing affordability.  We're proud that FreeStyle Libre Pro System achieves that for people with diabetes."   

Abbott's FreeStyle Libre Pro System, for professional use, is the second offering in Abbott's new category of sensing technology, Flash Glucose Monitoring.  The personal system, FreeStyle Libre Flash Glucose Monitoring System, was launched in seven European markets in October 2014.   

Abbott's FreeStyle Libre Pro system will be available to doctors in the coming weeks in six Indian cities including Mumbai, Delhi, Chennai, Bangalore, Pune and Trivandrum.

About Abbott

Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare.  With a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritional and branded generic pharmaceuticals, Abbott serves people in more than 150 countries and employs approximately 73,000 people.

Visit Abbott at www.abbott.com and connect with us on Twitter at @AbbottNews.

[1] http://indiatoday.intoday.in/story/obesity-india-weighs-third-on-obesity-scale/1/365876.html
[2] Misra A, Shrivastava U. Obesity and dyslipidemia in South Asians. Nutrients 2013; 5(7): 2708-33.)
[3] http://www.idf.org/BRIDGES/map/india
[4] The Abbott Sugar Survey, February 2015

SOURCE Abbott

Related Links

http://www.abbott.com

Modal title

Also from this source

Abbott recebe autorização da Anvisa para Ultreon™, tecnologia de imagem que usa inteligência artificial para artérias coronárias

Abbott recebe autorização da Anvisa para Ultreon™, tecnologia de imagem que usa inteligência artificial para artérias coronárias


FDA Approves Abbott's Spinal Cord Stimulation for People Living with Painful Diabetic Peripheral Neuropathy

FDA Approves Abbott's Spinal Cord Stimulation for People Living with Painful Diabetic Peripheral Neuropathy

Explore

More news releases in similar topics

  • Health Care & Hospitals
  • Household, Consumer & Cosmetics
  • Medical Pharmaceuticals
  • Retail
  • Pharmaceuticals

Contact Cision

  • Cision Distribution 888-776-0942
    from 8 AM - 9 PM ET

  • Chat with an Expert
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • Cision Communication Cloud®
  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • For Small Business
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • COVID-19 Resources
  • Accessibility Statement
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom

My Services

  • All New Releases
  • Online Member Center
  • ProfNet

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2023 Cision US Inc.